Modifier Genes as Therapeutics: The Nuclear Hormone Receptor Rev Erb Alpha (Nr1d1) Rescues Nr2e3 Associated Retinal Disease
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Nuclear hormone receptors play a major role in many important biological processes. Most nuclear hormone receptors are ubiquitously expressed and regulate processes such as metabolism, circadian function, and development. They function in these processes to maintain homeostasis through modulation of transcriptional gene networks. In this study we evaluate the effectiveness of a nuclear hormone receptor gene to modulate retinal degeneration and restore the integrity of the retina. Currently, there are no effective treatment options for retinal degenerative diseases leading to progressive and irreversible blindness. In this study we demonstrate that the nuclear hormone receptor gene Nr1d1 (Rev-Erbα) rescues Nr2e3-associated retinal degeneration in the rd7 mouse, which lacks a functional Nr2e3 gene. Mutations in human NR2E3 are associated with several retinal degenerations including enhanced S cone syndrome and retinitis pigmentosa. The rd7 mouse, lacking Nr2e3, exhibits an increase in S cones and slow, progressive retinal degeneration. A traditional genetic mapping approach previously identified candidate modifier loci. Here, we demonstrate that in vivo delivery of the candidate modifier gene, Nr1d1 rescues Nr2e3 associated retinal degeneration. We observed clinical, histological, functional, and molecular restoration of the rd7 retina. Furthermore, we demonstrate that the mechanism of rescue at the molecular and functional level is through the re-regulation of key genes within the Nr2e3-directed transcriptional network. Together, these findings reveal the potency of nuclear receptors as modulators of disease and specifically of NR1D1 as a novel therapeutic for retinal degenerations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have shown that modifier genes, such as nuclear hormone receptors, have the potential to “reset” various networks related to retinal disease phenotypes, such as photoreceptor development, phototransduction, metabolism, cone cell development, inflammation, and cell survival, thus restoring the homeostasis in the retina to a healthy state.47,50–53”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [51]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Modifier gene therapy has the potential to alter the retinal disease state even in the absence of a genetic diagnosis or in the absence of a gene therapy specific to the mutated gene in one of these patients.47,50–53”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Electroporation and RNA interference in the rodent retina in vivo and in vitro
Matsuda, T., & Cepko, C. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235688100 · Cited by 1,029
Jacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
Nuclear Receptor Rev-erbα Is a Critical Lithium-Sensitive Component of the Circadian Clock
Yin, L., Wang, J., Klein, P. S., & Lazar, M. A. (2006) · Science · doi:10.1126/science.1121613 · Cited by 556
Simonelli, F., Maguire, A. M., Testa, F., Pierce, E. A., Mingozzi, F., Bennicelli, J. L., Rossi, S., Marshall, K., Banfi, S., Surace, E. M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.277 · Cited by 553
Haider, N. B., Jacobson, S. G., Cideciyan, A. V., Swiderski, R., Streb, L. M., Searby, C., Beck, G., Hockey, R., Hanna, D. B., Gorman, S., et al. (2000) · Nature Genetics · doi:10.1038/72777 · Cited by 507
Self-citationStorch, K.-F., Paz, C., Signorovitch, J., Raviola, E., Pawlyk, B., Li, T., & Weitz, C. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.045 · Cited by 460 · cited 2×
“In the retina, both Nr2e3 and Nr1d1 mRNA levels oscillate over a 24-hour period [45].”
BackgroundCideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Pang, J.-J., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.086 · Cited by 312
Modifier genes in Mendelian disorders: the example of cystic fibrosis
Cutting, G. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05879.x · Cited by 271
Peng, G.-H., Ahmad, O., Ahmad, F., Liu, J., & Chen, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi070 · Cited by 270
Cheng, H. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh173 · Cited by 268
Zamir, I., Harding, H. P., Atkins, G. B., Hörlein, A., Glass, C. K., Rosenfeld, M. G., & Lazar, M. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5458 · Cited by 227 · cited 1×
“Specifically, the SNP lies within the binding domain for the NR1D1 co-repressor N-CoR, also known as X domain [41].”
BackgroundAkhmedov, N. B., Piriev, N. I., Chang, B., Rapoport, A. L., Hawes, N. L., Nishina, P. M., Nusinowitz, S., Heckenlively, J. R., Roderick, T. H., Kozak, C. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5551 · Cited by 221 · cited 2×
“Our previous studies revealed that genetic background strongly influences penetrance of Nr2e3 phenotypes [37,40].”
BackgroundHaider, N. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1619 · Cited by 202 · cited 3×
“Similar to patients with Nr2e3 mutations, rd7 mice exhibit significant increase of S-cones and progressive degeneration of rod and cone photoreceptor cells [38].”
BackgroundSelf-citationVision 1 Year after Gene Therapy for Leber's Congenital Amaurosis
Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Roman, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0903652 · Cited by 199
Sharon, D. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.9.1316 · Cited by 179
Corbo, J. C., & Cepko, C. L. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010011 · Cited by 174
Genotyping Microarray (Disease Chip) for Leber Congenital Amaurosis: Detection of Modifier Alleles
Zernant, J., Ku¨lm, M., Dharmaraj, S., den Hollander, A. I., Perrault, I., Preising, M. N., Lorenz, B., Kaplan, J., Cremers, F. P. M., Maumenee, I., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0111 · Cited by 170
Burris, T. P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0519 · Cited by 158
Retinal Circadian Clocks and Control of Retinal Physiology
Green, C. B., & Besharse, J. C. (2004) · Journal of Biological Rhythms · doi:10.1177/0748730404263002 · Cited by 144 · cited 1×
“The retina contains an intrinsic circadian clock that regulates many aspects of retinal physiology [49].”
BackgroundNuclear Receptor Rev-Erbα: A Heme Receptor that Coordinates Circadian Rhythm and Metabolism
Yin, L., Wu, N., & Lazar, M. A. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08001 · Cited by 143 · cited 1×
“As a circadian rhythm regulator, the cellular levels of Nr1d1 are tightly regulated and are a major determinant of circadian gene expression program [47,48].”
BackgroundUpdate on gene modifiers in cystic fibrosis
Collaco, J. M., & Cutting, G. R. (2008) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283121cdc · Cited by 143
Coppieters, F., Leroy, B. P., Beysen, D., Hellemans, J., Bosscher, K. D., Haegeman, G., Robberecht, K., Wuyts, W. A., Coucke, P. J., & Baere, E. B. W. D. (2007) · The American Journal of Human Genetics · doi:10.1086/518426 · Cited by 134
A Genome Scan for Modifiers of Age at Onset in Huntington Disease: The HD MAPS Study
Li, J.-L., Hayden, M. R., Almqvist, E. W., Brinkman, R. R., Durr, A., Dodé, C., Morrison, P. J., Suchowersky, O., Ross, C. A., Margolis, R. L., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/378133 · Cited by 126
Cheng, H., Aleman, T. S., Cideciyan, A. V., Khanna, R., Jacobson, S. G., & Swaroop, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl185 · Cited by 126
Adelmant, G., Bègue, A., Stéhelin, D., & Laudet, V (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3553 · Cited by 119 · cited 1×
“A second SNP was identified at position 2105 (Figures 2C and D), within the Nr1d1 promoter region [42,43].”
BackgroundSchorderet, D. F., & Escher, P. (2009) · Human Mutation · doi:10.1002/humu.21096 · Cited by 110
Self-citationIdentical mutations and phenotypic variation
Wolf, U. (1997) · Human Genetics · doi:10.1007/s004390050509 · Cited by 104 · cited 1×
“Genetic heterogeneity (identical mutations with variable clinical presentation of disease) is a common feature for many Mendelian disorders [1].”
BackgroundHaider, N. B., Mollema, N., Gaule, M., Yuan, Y., Sachs, A. J., Nystuen, A., Naggert, J. Κ., & Nishina, P. M. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.04.006 · Cited by 101
Self-citationFahim, A. T., Bowne, S. J., Sullivan, L. S., Webb, K. D., Williams, J. T., Wheaton, D. K., Birch, D. G., & Daiger, S. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023021 · Cited by 98
Lloret, A., Dragileva, E., Teed, A., Espinola, J., Fossale, E., Gillis, T., Lopez, E., Myers, R. H., MacDonald, M. E., & Wheeler, V. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl125 · Cited by 92
Modifier genes in humans: strategies for identification
Houlston, R. S., & Tomlinson, I. P. M. (1998) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200156 · Cited by 91
Mollema, N., Yuan, Y., Jelcick, A. S., Sachs, A. J., von Alpen, D. C., Schorderet, D. F., Escher, P., & Haider, N. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017494 · Cited by 89 · cited 6×
“Further, the NR1D1 and NR2E3 proteins interact with each other directly and regulate common genes/gene networks [26,45].”
BackgroundResultSelf-citationGerber, S., Rozet, J., Takezawa, S., Santos, L. C., Lopes, L., Gribouval, O., Penet, C., Perrault, I., Ducroq, D., Souied, E. H., et al. (2000) · Human Genetics · doi:10.1007/s004390000350 · Cited by 88
The transcription factor Nr2e3 functions in retinal progenitors to suppress cone cell generation
HAIDER, N. B., DEMARCO, P., NYSTUEN, A. M., HUANG, X., SMITH, R. S., MCCALL, M. A., NAGGERT, J. K., & NISHINA, P. M. (2006) · Visual Neuroscience · doi:10.1017/s095252380623027x · Cited by 86
Self-citationModifier genes and the plasticity of genetic networks in mice
Hamilton, B. A., & Yu, B. D. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002644 · Cited by 78 · cited 1×
“to uncover genetic modifiers that strongly influence phenotypic variation in human disease [15].”
BackgroundEvidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16
Djouss�, L., Knowlton, B. A., Hayden, M. R., Brinkman, R. R., Ross, C. A., Margolis, R. L., Rosenblatt, A., Dürr, A., Dodé, C., Morrison, P. J., et al. (2004) · Neurogenetics · doi:10.1007/s10048-004-0175-2 · Cited by 77
Mutations in NR2E3 can cause dominant or recessive retinal degenerations in the same family
Escher, P., Gouras, P., Roduit, R., Tiab, L., Bolay, S., Delarive, T., Chen, S., Tsai, C.-C., Hayashi, M., Zernant, J., et al. (2009) · Human Mutation · doi:10.1002/humu.20858 · Cited by 72 · cited 1×
“Interestingly, variable clinical presentation is observed even in patients harboring the same mutation and within the same family, suggesting that modifier genes modulate disease outcome in these patients [21,35,36].”
BackgroundSelf-citationGenetic modifiers affecting severity of epilepsy caused by mutation of sodium channelScn2a
Bergren, S. K., Chen, S., Gałecki, A. T., & Kearney, J. A. (2005) · Mammalian Genome · doi:10.1007/s00335-005-0049-4 · Cited by 68
Yanagi, Y., Takezawa, S., & Kato, S. (2002) · PubMed · Cited by 62
Chen, F., Figueroa, D. J., Marmorstein, A. D., Zhang, Q., Petrukhin, K., Caskey, C. T., & Austin, C. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15149 · Cited by 61
Minireview: The Role of Nuclear Receptors in Photoreceptor Differentiation and Disease
Forrest, D., & Swaroop, A. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1010 · Cited by 60 · cited 1×
“Nr1d1 and Nr2e3 are members of the nuclear hormone receptor family and as such they have a similar gene structure [46].”
BackgroundThe Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa.
Gire, A. I., Sullivan, L. S., Bowne, S. J., Birch, D. G., Hughbanks-Wheaton, D. K., Heckenlively, J. R., & Daiger, S. P. (2007) · PubMed · Cited by 56
Genetic modifiers of vision and hearing
Haider, N. B. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.10.1195 · Cited by 54
Self-citationGenetic modifiers of neurological disease
Kearney, J. A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.007 · Cited by 50
Dual role of Nr2e3 in photoreceptor development and maintenance
Webber, A. L., Hodor, P. G., Thut, C. J., Vogt, T., Zhang, T., Holder, D., & Petrukhin, K. E. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.04.006 · Cited by 50 · cited 1×
“NR2E3 is also expressed in mature photoreceptors where it regulates expression of genes essential for proper function, such as phototransduction genes [31,32].”
BackgroundDiscordant Phenotypes in Fraternal Twins Having an Identical Mutation in Exon ORF15 of the RPGR Gene
Walia, S. (2008) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2007.72 · Cited by 49
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington’s disease
Metzger, S., Bauer, P. O., Tomiuk, J., Laccone, F. A., DiDonato, S., Gellera, C., Soliveri, P., Lange, H. W., Weirich‐Schwaiger, H., Wenning, G. K., et al. (2005) · Neurogenetics · doi:10.1007/s10048-005-0023-z · Cited by 47
The Spectrum of Retinal Diseases Caused by NR2E3 Mutations in Israeli and Palestinian Patients
Bandah, D., Merin, S., Ashhab, M., Banin, E., & Sharon, D. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.615 · Cited by 42 · cited 1×
“Interestingly, variable clinical presentation is observed even in patients harboring the same mutation and within the same family, suggesting that modifier genes modulate disease outcome in these patients [21,35,36].”
BackgroundGenetic analysis of candidate genes modifying the age-at-onset in Huntington’s disease
Metzger, S., Bauer, P., Tomiuk, J., Laccone, F. A., DiDonato, S., Gellera, C., Mariotti, C., Lange, H. W., Weirich‐Schwaiger, H., Wenning, G. K., et al. (2006) · Human Genetics · doi:10.1007/s00439-006-0221-2 · Cited by 42
Haider, N. B., Zhang, W., Hurd, R., Ikeda, A., Nystuen, A. M., Naggert, J. K., & Nishina, P. M. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9092-2 · Cited by 41 · cited 9×
“Two suggestive quantitative trait loci (QTL) located on chromosomes 7 and 11 were found to be associated with suppression in the AKR/J genetic background [40].”
BackgroundMethodSelf-citationFine mapping of an epilepsy modifier gene on mouse Chromosome 19
Bergren, S. K., Rutter, E. D., & Kearney, J. A. (2009) · Mammalian Genome · doi:10.1007/s00335-009-9193-6 · Cited by 39
Modifiers of Hearing Impairment in Humans and Mice
Yan, D. L. S., & Liu, X.-Z. (2010) · Current Genomics · doi:10.2174/138920210791233054 · Cited by 22
Focus on Molecules: Nuclear hormone receptor Nr2e3: Impact on retinal development and disease
Mollema, N., & Haider, N. B. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.04.013 · Cited by 18 · cited 1×
“The NR2E3 protein contains four evolutionary conserved domains that are shared by the nuclear hormone receptor family; namely the highly variable A/B domain, N terminal DNA binding domain, a flexible hinge region and the ligand-binding and dimerization domain in the C terminus [33,34].”
BackgroundSelf-citationKakizawa, T., Nishio, S., Triqueneaux, G., Bertrand, S., Rambaud, J., & Laudet, V. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-06-0063 · Cited by 18
Phenotypic Intrafamilial Variability Associated with S212G Mutation in the RDS/Peripherin Gene
Passerini, I., Sodi, A., Giambene, B., Menchini, U., & Torricelli, F. (2007) · European Journal of Ophthalmology · doi:10.1177/112067210701700624 · Cited by 17
Cited by
From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health
Riordan, J. D., & Nadeau, J. H. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.004 · Cited by 168
“Fine-mapping of a candidate protective locus led to the identification of Nr1d1 (nuclear receptor subfamily 1, group D, member 1) as a modifier gene whose increased expression compensates for loss of Nr2e3 to eliminate the disease phenotype.(93) Nr1d1 encodes the nuclear hormone receptor Rev-erba, a target for which m…”
BackgroundGene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss
Collin, G. B., Gogna, N., Chang, B., Damkham, N., Pinkney, J., Hyde, L. F., Stone, L. V., Naggert, J. Κ., Nishina, P. M., & Krebs, M. P. (2020) · Cells · doi:10.3390/cells9040931 · Cited by 105
“Causality was confirmed by phenotypic rescue of the rd7-associated phenotypes by in vivo electroporation of a wild-type Nr1d1 expression construct [464].”
BackgroundOcular Clocks: Adapting Mechanisms for Eye Functions and Health
Felder‐Schmittbuhl, M., Buhr, E. D., Dkhissi‐Benyahya, O., Hicks, D., Peirson, S. N., Ribelayga, C., Sandu, C., Spessert, R., & Tosini, G. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24957 · Cited by 102
Li, S., Datta, S., Brabbit, E., Love, Z., Woytowicz, V., Flattery, K., Capri, J., Yao, K., Wu, S., Imboden, M., et al. (2021) · Gene Therapy · doi:10.1038/s41434-020-0134-z · Cited by 68
“Genetic modi fi ers play a key role in modulating disease onset, progression, and clinical outcome by either enhancing or suppressing disease [24, 40].”
BackgroundSelf-citation
Metadata
- Authors
- Cruz, N. M., Yuan, Y., Leehy, B. D., Baid, R., Kompella, U., DeAngelis, M. M., Escher, P., & Haider, N. B.
- Affiliations
- Massachusetts Eye and Ear Infirmary (US)
- University of Nebraska Medical Center (US)
- University of Colorado Anschutz (US)
- University of Utah (US)
- Institut de Recherche en Opthalmologie (CH)
- Corresponding author
- Haider, Neena B.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-01-31
- Volume
- 9
- Issue
- 1
- Pages
- e87942
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3909326
- OpenAlex
- W2031568258
- Cited by
- 47
- References
- 56
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 3
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- IRIS (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Open Access CRIS of the University of Bern
- Funders
- Massachusetts Lions Eye Research Fund
- Edward N. and Della L. Thome Memorial Foundation
- Hope For Vision
- National Institutes of Health
- U.S. Public Health Service (P20-RRO18788-03)
- National Eye Institute (RO1EY017653-01A2S1, RO1EY017653, R01EY017653, T32EY007145)
- National Center for Research Resources
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- NR1D1, NR2E3, retinal degeneration, nuclear receptors, retinitis pigmentosa, enhanced S-cone syndrome, genetic modifiers, gene therapy, transcriptional regulation, retinal disease therapy
- MeSH terms
- Animals, Humans, Mice, Transgenic, Retinal Degeneration, Retinitis Pigmentosa, Vision Disorders, Genetic Therapy, Eye Diseases, Hereditary, Mice, Nuclear Receptor Subfamily 1, Group D, Member 1, Orphan Nuclear Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.